0000950123-23-008479 Sample Contracts

Contract
Clinical Batch Development and Production Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

AutoNDA by SimpleDocs
SUBSCRIPTION AGREEMENT By and between Abivax S.A. as Issuer and Kreos Capital VII (UK) Limited Kreos Capital VII Aggregator SCSp Claret European Specialty Lending Company III, S.à r.l. Claret European Growth Capital Fund III SCSp As Subscribers
Subscription Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

This subscription agreement (hereinafter referred to as the “Subscription Agreement”) is entered into on 20 August 2023, by and between:

Contract
Drug Discovery Services Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
Manufacturing Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
Loan Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
Amendment N°1 • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

Contract
Loan Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
1st Amendment to Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
Financial Terms Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.

Contract
Intellectual Property Rights Pledge Deed • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

MASTER SERVICES AGREEMENT
Master Services Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

This Master Services Agreement (“Agreement”) effective as of 17th December, 2018 (“Effective Date”) is made between ABIVAX SA which has a place of business at 5, rue de la Baume—F-75008 Paris—France (“Sponsor”) and IQVIA Ltd of 500 Brook Drive, Green Park, Reading, Berkshire RG2 6UU (“IQVIA”). When signed by both parties, this Agreement will set forth the terms and conditions under which IQVIA agrees to provide certain services to Sponsor as set forth herein.

Contract
Tranche a-B Warrants Issue Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

Contract
Ocabsa Issue Agreement • September 8th, 2023 • Abivax S.A. • Pharmaceutical preparations

Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!